Abstract

Telemedicine usage has increased significantly in the past year due to the COVID-19 pandemic. As reported by the Centers for Disease Control and Prevention, there was a 154% increase in telehealth visits during the last week of March 2020 compared to the same time in 2019.1 As public health organizations maintain current social distancing guidelines, this platform can help overcome barriers in access to health care while minimizing the risk of exposure to COVID-19. This can be particularly helpful in dermatology, a field in which there is a high clinic volume and whose patients often require long-term use of immunomodulatory medications.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.